Geron (GERN) EBIT (2010 - 2026)

Geron has disclosed EBIT across 17 years of filings, most recently posting $158000.0 for Q1 2026.

• EBIT for Q1 2026 came in at $158000.0, up 100.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$51.7 million (up 61.49% YoY), and the FY2025 annual result was -$68.6 million, up 60.52% from the prior year.
• EBIT came in at $158000.0 for Q1 2026 at Geron, up from -$25.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $158000.0 in Q1 2026 to a low of -$69.3 million in Q2 2024.
• The 5-year median for EBIT is -$28.7 million (2022), against an average of -$33.8 million.
• Across the five-year window, EBIT sank 85.7% in 2023 and soared 100.95% in 2026, its largest moves.
• Geron's EBIT stood at -$42.0 million in 2022, then dropped by 29.41% to -$54.3 million in 2023, then surged by 63.07% to -$20.0 million in 2024, then declined by 27.38% to -$25.5 million in 2025, then jumped by 100.62% to $158000.0 in 2026.
• The last three EBIT figures came in at $158000.0 (Q1 2026), -$25.5 million (Q4 2025), and -$13.9 million (Q3 2025), per Business Quant data.